44 results about "Mutation screening" patented technology

Glycosyltransferase UGT76G1 and UGT91C1 mutants and a method for catalytic synthesis of rebaudioside A, D, and M by using same, pertaining to the technical field of biocatalytic synthesis. The glycosyltransferase UGT76G1 mutant can effectively synthesize rebaudioside A using stevioside STV as a substrate. The glycosyltransferase UGT91C1 mutant is obtained by mutation screening of wild-type glycosyltransferase UGT91C1, has higher enzyme activity and catalytic rate, and can effectively synthesize rebaudioside D using rebaudioside A as a substrate. The glycosyltransferase UGT76G1 mutant can also be obtained by mutation and subsequent screening of glycosyltransferase UGT76G1, has higher catalytic activity, and can effectively synthesize rebaudioside M using rebaudioside D and UDPG as substrates.

The invention belongs to the technical field of bioengineering, and particularly relates to a zearalenone toxin degrading enzyme variant and application thereof. The amino acid sequence of the zearalenone toxin degrading enzyme is as shown in SEQ ID NO.2, or the zearalenone toxin degrading enzyme with the amino acid sequence as shown in SEQ ID NO.2 is obtained through amino acid mutation. The zearalenone toxin degrading enzyme mutant is obtained through mutation screening, and compared with a wild type, the zearalenone toxin degrading enzyme mutant has the advantages that the zearalenone degrading capability is obviously improved; besides, the zearalenone toxin degrading enzyme is expressed by using alfalfa, the zearalenone toxin degrading enzyme with biological activity is easy to obtain, and the zearalenone toxin degrading enzyme has certain application potential in prevention and treatment of animal poisoning caused by zearalenone toxin pollution in agriculture and animal husbandry production.

The invention discloses a related gene for improving corn ear rot resistance and an application method thereof, the gene is (a1) or (a2) or (a3), and the protein is (b1) or (b2). The invention also discloses application of the ZmNFXL1 gene, the protein, or the inhibiting factor thereof, or a biological material containing the coding gene or the inhibiting factor thereof. The corn spike rot resistance gene ZmNFXL1 is found for the first time, and the corn spike rot resistance can be remarkably improved by blocking the expression of the gene through a natural mutation screening or manual intervention method. Meanwhile, according to the method disclosed by the invention, the spike rot resistant corn germplasm can be quickly identified and created, so that the influence of the spike rot on corn planting can be reduced.

The invention discloses a polypeptide (NP1706, SEQ ID NO: 6) derived from the skin of nanorana parkeri, a polypeptide derivative as well as a composition and application of the polypeptide derivative. A natural parent peptide (NP1711, SEQ ID NO: 11) is optimized by combining a polypeptide activity prediction system with a molecular design technology, systematic mutation screening finds that the 5th site, the 9th site and the 14th site are active non-essential residues, and variant derivatives obtained by performing site-directed mutagenesis on the 5th site, the 9th site and the 14th site do not significantly change the original biological activity. The pharmacological activity and safety parameters of the NP1706 show optimal balance, so that the NP1706 is determined as the optimal candidate polypeptide. Based on the polypeptide and the polypeptide derivative, the activities of promoting cell proliferation and migration, resisting oxidation, resisting inflammation and the like are provided, and the application of the polypeptide and the polypeptide derivative in cosmetics and medicines is provided. The invention has the advantages of simple synthesis, good safety and excellent biological activity, and can be widely applied to the fields of skin repair, aging resistance, wound healing, inflammation resistance and the like.

The present invention provides a kit, method and application for detecting human membranous nephropathy-related indicators. Through multiple mutation screenings of the coding nucleotide sequences of PLA2R antigen and THSD7A antigen, the most optimized sequences of PLA2R antigen and THSD7A antigen are obtained. The dialysis fluid formula in the preparation and purification processes of PLA2R antigen and THSD7A antigen, as well as the preservation fluid formula of PLA2R antigen and THSD7A antigen, are optimized. Highly pure PLA2R antigen and THSD7A antigen are prepared, and the problems of instability and batch-to-batch variation of PLA2R antigen and THSD7A antigen are solved to the greatest extent. The prepared kit can significantly improve the accuracy and sensitivity of detection, control batch-to-batch variation, and achieve rapid, accurate, simple and efficient detection of human membranous nephropathy-related indicators.

The invention relates to the field of kits, in particular to a deafness-related gene mutation screening kit. The kit comprises an amplification primer, a PCR (Polymerase Chain Reaction) amplification enzyme reaction reagent, enzyme-free water, a magnetic bead purification reagent, a sequencing primer, a sequencing reaction reagent and a sequencing product purification reagent, wherein the amplification primer is designed for mutation of 26 sites in GJB2, GJB3, SLC26A4 and mitochondrial 12S rRNA genes; the magnetic bead purification reagent is used for purifying amplification products. An amplification primer follows the design principle that the distance between the amplification primer and a mutation site is at least 50 bases or above, and high-frequency single nucleotide polymorphic sites are avoided, PCR amplification adopts a falling annealing temperature control program, an amplification product is purified through a magnetic bead purification system, sequencing reaction configures an optimized working enzyme system, a specific thermal cycle program is adopted, and the high-frequency single nucleotide polymorphisms are obtained. And finally carrying out first-generation sequencing analysis. The method can realize high-specificity, high-sensitivity and high-stability detection of deafness-related gene multi-site mutation, and has the advantages of simplicity and convenience in operation, accurate result and wide application range.

This invention provides a 7β-HSDH enzyme mutant, its encoding gene, and its applications. Through artificial mutation screening, 7α-HSDH and 7β-HSDH enzyme mutants with specific amino acid sequences were identified, resulting in improved enzyme activity and catalytic efficiency compared to wild-type 7α-HSDH and wild-type 7β-HSDH. This invention also provides a method for preparing ursodeoxycholic acid using the aforementioned 7α-HSDH and 7β-HSDH enzyme mutants, specifically using NADP... + A one-pot catalytic method for the conversion of chenodeoxycholic acid to ursodeoxycholic acid using NADPH-dependent 7α-HSDH enzyme mutants and NADPH-dependent 7β-HSDH enzyme mutants is employed. This method is simple, yields high product conversion, and can also achieve the conversion of the coenzyme NADP. + / NADPH's self-circulating regeneration eliminates the need for auxiliary enzymes and raw materials used in coenzyme regeneration, greatly reducing production costs and environmental pressure, and possessing enormous potential for industrial applications.

The invention discloses a device and method for screening key mutations affecting virus host adaptability based on a deep learning model, and the method comprises the following steps: 1) based on a specified pathogen type, collecting gene sequence data of a pathogen and adopted host information, and preprocessing the collected data, constructing a model training data set and a test data set; 2) performing feature extraction on the collected sequence data to obtain a feature matrix of each sequence; 3) constructing a deep learning convolutional neural network model to perform data training and feature learning on the training data set; according to the method, the problem that measurement is inaccurate due to the fact that homology between virus hosts is high is solved, and the method has more accurate host adaptability prediction capacity and key mutation screening capacity.

The invention relates to the technical field of enzyme engineering, in particular to a malic enzyme mutant and application thereof. Specifically, the malic enzyme derived from Escherichia coli is subjected to site mutation screening, and results show that after methionine at the 144th site is mutated into isoleucine (M144I), glutamine at the 253rd site is mutated into isoleucine (Q253I), and threonine at the 327th site is mutated into phenylalanine (T327F), the catalytic efficiency and the catalytic activity are obviously improved, which is of great significance to industrial application.

The application discloses a base editor ACGBEmax realizing simultaneous replacement of purine and pyrimidine, relates to the technical field of gene editing, and comprises, from N end to C end, an HMCES protein, a bifunctional deaminase TadDual, an nCas9(D10A) protein and an engineered N-methyl purine DNA glycosylase eMPG. The base editor can realize simultaneous replacement of purine and pyrimidine, significantly increases the diversity of mutants after targeted editing, has the advantages of high editing efficiency and low Indels rate, and has great application value in aspects of in vitro and in vivo protein mutation screening and identification of oncogenic amino acid mutations.

This invention discloses a STAT3-mutated cell product and its uses, belonging to the interdisciplinary field of genetic engineering and tumor immunotherapy. Through saturation mutation screening, this invention is the first to discover that STAT3 gain-of-function mutations promote CAR-T anti-tumor responses. Furthermore, through cell and animal experiments, it is demonstrated that activating STAT3 can alleviate CAR-T cell immune exhaustion and significantly enhance the in vivo and in vitro killing ability of CAR-T cells against tumor cells, thereby improving the efficacy of anti-tumor therapy. This invention provides a new therapeutic target and strategy for the field of tumor immunotherapy, possessing significant scientific and clinical application value.

The invention belongs to the technical field of agricultural biology, and particularly discloses a grape germplasm innovation method based on X-ray gradient mutagenesis and an LD50 precise prediction model, and the method comprises the following steps: selecting an annual grape branch for vernalization treatment, and trimming the annual grape branch into a single-bud stem segment; setting an irradiation time gradient, accurately calculating an LD50 value through a cubic spline interpolation model, and carrying out X-ray irradiation on the single-bud stem segment according to the LD50 value; after irradiation, performing cutting and liquid paraffin sealing, and then performing cuttage, potting and field planting treatment; performing secondary vernalization on mutagenesis plant branches, trimming the mutagenesis plant branches into single-bud stem segments, collecting tender leaves after cutting survival, extracting genome DNA, performing whole genome sequencing, and accurately distinguishing mutagenesis specific variation and natural variation. By establishing a complete technical system of standardized vernalization, gradient irradiation, LD50 accurate calculation and whole genome verification, the problems of inaccurate irradiation parameters, nonstandard material treatment, low mutation screening accuracy and the like in the prior art are solved.

The invention provides a kit for detecting cytokines based on a flow fluorescence method and application of the kit, aiming at 12 cytokines, antibody 1 sequences and antibody 2 sequences of the 12 cytokines are respectively screened and optimized, and humanized recombinant antibodies are prepared through expression of an eukaryotic cell expression system; wherein the antibody 1 is used for preparing an antibody solution of coupled microspheres, and the antibody 2 is used for preparing a fluorescently-labeled antibody solution; multiple mutation screening and heavy chain and light chain combination pairing screening are carried out on the IL-17A antibody sequence which is most difficult to detect, so that the optimal IL-17A antibody 1 and IL-17A antibody 2 sequences are obtained. The prepared kit realizes simultaneous detection of 12 cell factors through a flow cytometer, only one-time incubation and one-time washing are needed in the detection process, the detection accuracy and sensitivity can be improved, the batch difference can be controlled, and accurate detection of serum samples and plasma samples can be realized.

The invention discloses a base editor ACGBEmax for simultaneously realizing purine and pyrimidine substitution, and relates to the technical field of gene editing, and the base editor ACGBEmax sequentially comprises an HMCES protein, a bifunctional deaminase TadDual, an nCas9 (D10A) protein and an engineered N-methylpurine DNA glycosylase eMPG from an N terminal to a C terminal. The base editor can realize replacement of purine and pyrimidine at the same time, significantly increases the diversity of mutants after targeted editing, has the advantages of high editing efficiency and low Indels rate, and has great application value in the aspects of in-vivo and in-vitro protein mutation screening, carcinogenic amino acid mutation identification and the like.

The invention relates to the technical field of gene engineering and protein modification, in particular to a lipase mutant and application thereof in synthesis of a pregabalin key chiral intermediate. According to the invention, on the basis of thermomyces lanuginosus lipase TL, a large amount of mutation screening is carried out, so that the lipase mutant of which the catalytic efficiency of hydrolysis of 2-carboxyethyl-3-cyano-5-methyl ethyl hexanoate (CNDE) is remarkably improved is finally obtained. Wherein the catalytic constant Kcat of the single-point mutant containing S254A reaches 100.2 and is 45 times of that of a wild type, the enantiomer selectivity ee value of the single-point mutant containing S254A is also higher than that of the wild type, and an unexpected technical effect is achieved. The lipase mutant can be applied to efficient synthesis of a pregabalin key chiral intermediate, and has a wide prospect.

This invention relates to the fields of genetic engineering and protein modification technology, specifically to a lipase mutant and its application in the synthesis of a key chiral intermediate of pregabalin. This invention relates to *Thermophilus spp.* (…). Thermomyces lanuginosus Based on lipase TL, through extensive mutation screening, a lipase mutant with significantly improved catalytic efficiency for the hydrolysis of ethyl 2-carboxyethyl-3-cyano-5-methylhexanoate (CNDE) was finally obtained. Among them, the single-point mutant containing S254A has a catalytic constant... K The cat value reached 100.2, which is 45 times that of the wild type, and the enantioselectivity ee value was also higher than that of the wild type, achieving unexpected technical results. This lipase mutant has broad prospects for the efficient synthesis of key chiral intermediates of pregabalin.

The invention relates to the technical field of enzyme engineering, in particular to a malic enzyme mutant and application thereof. Specifically, the malic enzyme derived from Escherichia coli is subjected to site mutation screening, and the result shows that after valine at the 7th site is mutated into lysine (V7K), the catalytic efficiency and the catalytic activity are obviously improved, which is of great significance to industrial application.

This invention discloses an imine reductase mutant and its application in catalyzing the synthesis of amine compounds. The invention utilizes an ultra-high performance liquid chromatography (UHPLC) method to detect the source... Acidovorax Novel imine reductase Ac IRED mutation screening yielded a super mutant with high activity, high stability, and broader applicability to non-natural substrates. This mutant exhibited enhanced catalytic performance against 1-naphthyl ethylone and cyclopropylamine, and also improved activity against various ketone compounds and multiple amine nucleophiles. This invention… Ac IRED-M5 mutant activity compared to wild type Ac Compared to IRED-WT, it improved by 41.5 times, and the product... e.e. Values ​​above 99%; mutant Ac IRED-M8 mutant activity compared to wild type Ac Compared to IRED-WT, it improved by 120.5 times, with substrate conversion >90%, and product... e.e. With a value of over 99%, it has the potential for industrial applications.

The invention relates to a D-erythrose-4-phosphate dehydrogenase mutant and application of the D-erythrose-4-phosphate dehydrogenase mutant in construction of a strain for producing vitamin B6, the D-erythrose-4-phosphate dehydrogenase mutant is obtained through mutation screening, and the strain constructed by using the D-erythrose-4-phosphate dehydrogenase mutant can produce vitamin B6 at high yield.

This invention provides a 7α-HSDH enzyme mutant and a 7β-HSDH enzyme mutant, their encoding genes, and their applications. Through artificial mutation screening, 7α-HSDH and 7β-HSDH enzyme mutants with specific amino acid sequences were identified, resulting in improved enzyme activity and catalytic efficiency compared to wild-type 7α-HSDH and wild-type 7β-HSDH. This invention also provides a method for preparing ursodeoxycholic acid using the aforementioned 7α-HSDH and 7β-HSDH enzyme mutants, specifically using NADP... + A one-pot catalytic method for the conversion of chenodeoxycholic acid to ursodeoxycholic acid using NADPH-dependent 7α-HSDH enzyme mutants and NADPH-dependent 7β-HSDH enzyme mutants is employed. This method is simple, yields high product conversion, and can also achieve the conversion of the coenzyme NADP. + / NADPH's self-circulating regeneration eliminates the need for auxiliary enzymes and raw materials used in coenzyme regeneration, greatly reducing production costs and environmental pressure, and possessing enormous potential for industrial applications.

The invention relates to the technical field of gene engineering and protein modification, in particular to a lipase mutant and application thereof in synthesis of a pregabalin key chiral intermediate. According to the invention, on the basis of thermomyces lanuginosus lipase TL, a large amount of mutation screening is carried out, so that the lipase mutant of which the catalytic efficiency of hydrolysis of 2-carboxyethyl-3-cyano-5-methyl ethyl hexanoate (CNDE) is remarkably improved is finally obtained. Wherein the catalytic constant Kcat of the single-point mutant containing S254A reaches 100.2 and is 45 times of that of a wild type, the enantiomer selectivity ee value of the single-point mutant containing S254A is also higher than that of the wild type, and an unexpected technical effect is achieved. The lipase mutant can be applied to efficient synthesis of a pregabalin key chiral intermediate, and has a wide prospect.

The invention relates to the technical field of biology, and discloses a pichia pastoris engineering strain for producing Candida antarctica lipase B. A lipase mutant construction method comprises the following steps: step 1, constructing a carrier signal peptide of recombinant pichia pastoris for producing CALB; a pichia pastoris plasmid vector pGAPZ alpha A is subjected to three substitutions, namely SP23, M alpha and MF delta, the signal peptide is subjected to recombinant strain construction and screening, and the expression quantity of CALB synthesized by different strains is measured through shake flask fermentation. According to the pichia pastoris engineering strain for producing the Candida antarctica lipase B, a site-directed single mutation treatment experiment is carried out on a CALB gene segment, a recombinant pichia pastoris strain for producing CALB with good thermal stability is screened out, and the number of a recombinant plasmid of the recombinant pichia pastoris strain is pGAPZ (M alpha) A-CALB-Q231F; the protein expression quantity signal peptide is subjected to mutation screening, the screening finds that the expression quantity of pGAPZ (M alpha) A protein is relatively high, and the actual expression quantity of 150L fermentation protein is up to 2.02 g / L.

The invention discloses a kit for rapidly detecting human ALDH2 genotypes and a use method thereof. The kit comprises a group of primers and probes for real-time fluorescent quantitative PCR detection of ALDH2, a high-stress-resistance rapidly-amplified DNA polymerase obtained by site-directed mutagenesis screening based on wild Taq enzyme, and a sample detection extraction-free reagent. By utilizing the combination, the rapid detection of the human ALDH2 gene can be realized, and a single reaction can be completed within 20 minutes, so that the detection efficiency is greatly improved.

The application belongs to the technical field of molecular markers, and provides a Hu sheep 5K low-density SNP chip and application thereof.The chip comprises 5000 SNP molecular markers, and the SNP molecular markers are shown in Table 1.Based on resequencing data of Hu sheep, the application screens SNP markers with rich polymorphic information content of Hu sheep breeds, integrates functional variation sites such as nonsense mutations and splicing mutations, and customizes the 5K low-density chip of Hu sheep, which can be used for Hu sheep kinship identification and functional harmful mutation screening.

The invention discloses a construction method and application of an adeno-associated virus vector of a targeted vascular endothelial cell, and belongs to the technical field of genetic engineering. The construction method and the application comprise the following steps: S1, vector construction: cloning a Tie2-eNOS promoter to a pAAV-MCS plasmid, so as to obtain pAAV-Tie2-MCS; the preparation method comprises the following steps: carrying out PCR (Polymerase Chain Reaction) amplification on a VEGF (Vascular Endothelial Growth Factor) gene, and inserting the VEGF gene into a pAAV-MCS plasmid to obtain an expression plasmid pAAV-Tie2- The method comprises the following steps: carrying out combined mutation on a VP1 gene of a pAAV-RC6 plasmid to obtain a mutant plasmid pAAV-RC6; s2, virus packaging and purification: culturing an HEK293 cell, and transfecting a pAAV-Tie2-VEGF (Vascular Endothelial Growth Factor), a mutant plasmid pAAV-RC6 and a pHelper plasmid; performing chromatographic purification by combining iodixanol gradient centrifugation with Heparin, so as to obtain rAAV; and S3, carrying out titer determination, SDS-PAGE (Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis) and in vitro and in vivo experiment detection on the rAAV. The preparation process is simple, the titer greater than or equal to 1 * 10 < 13 > vg / mL can be obtained through single transfection, and the production cost is reduced; and mutation screening is realized through a directed evolution technology, so that the experimental period is shortened. And the vector provided by the invention has relatively high specificity on vascular endothelial cells.

The application discloses a cembranoid alcohol synthase mutant and application thereof in biosynthesis of cembranoid alcohol, and belongs to the field of enzyme engineering and synthetic biology. The mutant with significantly improved catalytic performance is obtained by rational design and mutation screening of cembranoid alcohol synthase (NtCBTS) from tobacco. The cembranoid alcohol yield of the strain containing the mutant NtCBTS_K208R-A268C-K353R is increased by 231.18% compared with the strain containing NtCBTS. The mutant is applied to a Saccharomyces cerevisiae expression system, and efficient biosynthesis of cembranoid alcohol is realized, and the generation level of the target product is significantly improved. The high-activity enzyme mutant and the application strategy provided by the application effectively improve the biosynthesis efficiency of cembranoid alcohol, and provide important technical support for constructing a high-yield yeast cell factory and promoting industrialized production.

The application discloses a glycosyltransferase UGT91C1 mutant and a method for catalyzing synthesis of rebaudioside D, and belongs to biological catalytic synthesis. The glycosyltransferase UGT91C1 mutant is any one of the following (A)-(C): A) a protein obtained by making any one or more mutations in the amino acid sequence shown in SEQ ID NO. 1: the 89th amino acid is mutated from N to Y; the 155th amino acid is mutated from M to L; the 274th amino acid is mutated from S to T; and the 361st amino acid is mutated from N to S; (B) a protein having 95% or 98% or above identity with the amino acid sequence defined in (A) and having the same function; and (C) a fusion protein obtained by connecting a tag to the end of the protein defined in (A) or (B). The glycosyltransferase UGT91C1 mutant is obtained by mutation screening from a wild-type glycosyltransferase UGT91C1, has higher enzyme activity and catalytic rate, and can efficiently synthesize rebaudioside D by taking rebaudioside A as a substrate.

The invention relates to the technical field of bioinformatics, in particular to a mutation screening method of cellobiose epimerase and related equipment. According to the method provided by the embodiment of the invention, a protein diffusion model is adopted to reconstruct the key catalytic region to obtain a regenerated mutant protein skeleton; performing side chain optimization on the mutant protein skeleton by using a deep learning neural network model to obtain a predicted amino acid sequence of the mutant protein skeleton; obtaining a three-dimensional structure of a cellobiose epimerase mutant-substrate compound according to the predicted amino acid sequence and a molecular structure of a substrate, and screening the three-dimensional structure of the cellobiose epimerase mutant-substrate compound; through the mode, the mutation screening efficiency of the key catalytic region can be improved, the mutant capable of improving the conversion efficiency of lactulose can be rapidly screened, and the screening efficiency of the cellobiose epimerase mutant with the improved conversion efficiency of lactulose is improved.

The invention belongs to the technical field of bioengineering, and particularly relates to cellulase for degrading waste plant fibers and a mutant thereof. The amino acid sequence of the cellulase mutant is as shown in SEQ ID NO.3, and the nucleotide sequence of the cellulase mutant is as shown in SEQ ID NO.4. The cellulase mutant is obtained through mutation screening, compared with wild type cellulase, the enzyme activity of the cellulase mutant is obviously improved, and the cellulase mutant has more excellent pH stability and heat stability and larger industrial application potential. In addition, the high-performance super absorbent resin is prepared by grafting acrylic acid after the waste plant fibers are pretreated by the cellulase mutant, and an innovative solution is provided for realizing resource utilization of agricultural wastes.

The application provides a lytic polysaccharide monooxygenase mutant, a preparation method and application thereof, relates to the technical field of enzyme engineering, and is based on wild-type Myceliophthora thermophila lytic polysaccharide monooxygenase, and a V143I mutation is generated to obtain the lytic polysaccharide monooxygenase, wherein the amino acid sequence of the wild-type Myceliophthora thermophila lytic polysaccharide monooxygenase is shown in SEQ ID NO. 1. In the application, the lytic polysaccharide monooxygenase gene derived from Myceliophthora thermophila C1 is rationally designed, and a lytic polysaccharide monooxygenase mutant gene with improved thermal stability is obtained through mutation screening. Subsequently, the Pichia pastoris expression system is used to express and prepare the lytic polysaccharide monooxygenase mutant with improved heat resistance, the lytic enzyme is modified through engineering, the enzymatic properties such as activity and stability of the lytic enzyme are effectively improved, and the lytic enzyme can be successfully applied in the degradation of pulp cellulose.